Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, 200080, Shanghai, China; National Clinical Research Center for Eye Diseases, 200080, Shanghai, China; Shanghai Key Laboratory of Fundus Diseases, 200080, Shanghai, China; Shanghai Engineering Center for Visual Science and Photomedicine, 200080, Shanghai, China; Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, 200080, Shanghai, China.
Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, 200080, Shanghai, China; National Clinical Research Center for Eye Diseases, 200080, Shanghai, China; Shanghai Key Laboratory of Fundus Diseases, 200080, Shanghai, China; Shanghai Engineering Center for Visual Science and Photomedicine, 200080, Shanghai, China; Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Diseases, 200080, Shanghai, China.
Exp Eye Res. 2021 Sep;210:108718. doi: 10.1016/j.exer.2021.108718. Epub 2021 Aug 6.
Diabetic retinopathy (DR) is an irreversible and progressive diabetic complication leading to visual impairment, even blindness. Due to the delicate and complicated structure of the retina, the pathology of DR has not been completely elucidated yet. We constructed a transcriptome atlas of >14,000 single cells from healthy and streptozotocin (STZ)-induced diabetic murine retinas to decipher pathological alterations of DR. We found four stress-inducible genes Cirbp, Rmb3, Mt1 and Mt2 commonly induced in most types of retinal cells. Bipolar cells were little affected on both number and gene expression. Diabetes increased expression of inflammatory factor genes in retinal microglia, and stimulated expression of immediate early genes (IEGs) in retinal astrocytes. A large number of genes were deregulated in diabetic vascular endothelial cells (ECs), and the differentially expressed genes were paired to the pathways functioning in metabolism, shear stress and vascular permeability. These pathways were mapped by more deregulated genes in a subpopulation of ECs specifically presented in diabetic retinas (diabetic retinal ECs, DRECs). Moreover, several inflammation pathways were activated in DRECs, and the most significant one is the IL-17 signaling pathway. According to the EC markers, DRECs were mainly capillary ECs, confirmed by immunofluorescent staining of S100a9, a target gene of the IL-17 signaling pathway. This study deciphered pathological alterations of DR, and provided clues for potential targets for DR therapy.
糖尿病性视网膜病变(DR)是一种不可逆且进行性的糖尿病并发症,可导致视力损害,甚至失明。由于视网膜结构精细而复杂,DR 的病理尚未完全阐明。我们构建了一个超过 14000 个来自健康和链脲佐菌素(STZ)诱导的糖尿病鼠视网膜的单细胞转录组图谱,以破译 DR 的病理改变。我们发现了四个应激诱导基因 Cirbp、Rmb3、Mt1 和 Mt2,它们在大多数类型的视网膜细胞中普遍诱导。双极细胞在数量和基因表达上都很少受到影响。糖尿病增加了视网膜小胶质细胞中炎症因子基因的表达,并刺激了视网膜星形胶质细胞中即刻早期基因(IEGs)的表达。大量基因在糖尿病血管内皮细胞(ECs)中失调,差异表达的基因与代谢、剪切应力和血管通透性相关的通路功能相关。这些通路通过在糖尿病视网膜(DRECs)中特异性出现的 EC 亚群中更多失调的基因来映射。此外,几个炎症通路在 DRECs 中被激活,其中最显著的是 IL-17 信号通路。根据 EC 标志物,DRECs 主要是毛细血管 ECs,通过 IL-17 信号通路的靶基因 S100a9 的免疫荧光染色得到证实。本研究破译了 DR 的病理改变,并为 DR 治疗的潜在靶点提供了线索。